234 related articles for article (PubMed ID: 29901068)
21. PDZ binding kinase (PBK) is a theranostic target for nasopharyngeal carcinoma: driving tumor growth via ROS signaling and correlating with patient survival.
Wang MY; Lin ZR; Cao Y; Zheng LS; Peng LX; Sun R; Meng DF; Xie P; Yang JP; Cao L; Xu L; Huang BJ; Qian CN
Oncotarget; 2016 May; 7(18):26604-16. PubMed ID: 27049917
[TBL] [Abstract][Full Text] [Related]
22. PBK/TOPK, a proliferating neural progenitor-specific mitogen-activated protein kinase kinase.
Dougherty JD; Garcia AD; Nakano I; Livingstone M; Norris B; Polakiewicz R; Wexler EM; Sofroniew MV; Kornblum HI; Geschwind DH
J Neurosci; 2005 Nov; 25(46):10773-85. PubMed ID: 16291951
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of PBK/TOPK Contributes to Tumor Development and Poor Outcome of Esophageal Squamous Cell Carcinoma.
Ohashi T; Komatsu S; Ichikawa D; Miyamae M; Okajima W; Imamura T; Kiuchi J; Nishibeppu K; Kosuga T; Konishi H; Shiozaki A; Fujiwara H; Okamoto K; Tsuda H; Otsuji E
Anticancer Res; 2016 Dec; 36(12):6457-6466. PubMed ID: 27919968
[TBL] [Abstract][Full Text] [Related]
24. PBK/TOPK is a novel mitotic kinase which is upregulated in Burkitt's lymphoma and other highly proliferative malignant cells.
Simons-Evelyn M; Bailey-Dell K; Toretsky JA; Ross DD; Fenton R; Kalvakolanu D; Rapoport AP
Blood Cells Mol Dis; 2001; 27(5):825-9. PubMed ID: 11783945
[TBL] [Abstract][Full Text] [Related]
25. PDZ-binding kinase/T-LAK cell-originated protein kinase, a putative cancer/testis antigen with an oncogenic activity in breast cancer.
Park JH; Lin ML; Nishidate T; Nakamura Y; Katagiri T
Cancer Res; 2006 Sep; 66(18):9186-95. PubMed ID: 16982762
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of artesunate for the treatment of adult T-cell leukemia/lymphoma.
Ishikawa C; Senba M; Mori N
Eur J Pharmacol; 2020 Apr; 872():172953. PubMed ID: 31996318
[TBL] [Abstract][Full Text] [Related]
27. Expression of PDZ-binding kinase/T-LAK cell-originated protein kinase (PBK/TOPK) in human urinary bladder transitional cell carcinoma.
Singh PK; Srivastava AK; Dalela D; Rath SK; Goel MM; Bhatt ML
Immunobiology; 2014 Jun; 219(6):469-74. PubMed ID: 24629784
[TBL] [Abstract][Full Text] [Related]
28. Suppression of the solar ultraviolet-induced skin carcinogenesis by TOPK inhibitor HI-TOPK-032.
Roh E; Han Y; Reddy K; Zykova TA; Lee MH; Yao K; Bai R; Curiel-Lewandrowski C; Dong Z
Oncogene; 2020 May; 39(21):4170-4182. PubMed ID: 32277233
[TBL] [Abstract][Full Text] [Related]
29. Phosphorylation of IκBα at serine 32 by T-lymphokine-activated killer cell-originated protein kinase is essential for chemoresistance against doxorubicin in cervical cancer cells.
Park JH; Yoon DS; Choi HJ; Hahm DH; Oh SM
J Biol Chem; 2013 Feb; 288(5):3585-93. PubMed ID: 23250755
[TBL] [Abstract][Full Text] [Related]
30. The Protective Role of the TOPK/PBK Pathway in Myocardial Ischemia/Reperfusion and H₂O₂-Induced Injury in H9C2 Cardiomyocytes.
Sun G; Ye N; Dai D; Chen Y; Li C; Sun Y
Int J Mol Sci; 2016 Feb; 17(3):267. PubMed ID: 26907268
[TBL] [Abstract][Full Text] [Related]
31. PBK/TOPK Expression Predicts Prognosis in Oral Cancer.
Chang CF; Chen SL; Sung WW; Hsieh MJ; Hsu HT; Chen LH; Chen MK; Ko JL; Chen CJ; Chou MC
Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27347940
[TBL] [Abstract][Full Text] [Related]
32. PDZ-binding kinase/T-LAK cell-originated protein kinase is a target of the fucoidan from brown alga Fucus evanescens in the prevention of EGF-induced neoplastic cell transformation and colon cancer growth.
Vishchuk OS; Sun H; Wang Z; Ermakova SP; Xiao J; Lu T; Xue P; Zvyagintseva TN; Xiong H; Shao C; Yan W; Duan Q; Zhu F
Oncotarget; 2016 Apr; 7(14):18763-73. PubMed ID: 26936995
[TBL] [Abstract][Full Text] [Related]
33. Novel selective TOPK inhibitor SKLB-C05 inhibits colorectal carcinoma growth and metastasis.
Gao T; Hu Q; Hu X; Lei Q; Feng Z; Yu X; Peng C; Song X; He H; Xu Y; Zuo W; Zeng J; Liu Z; Yu L
Cancer Lett; 2019 Mar; 445():11-23. PubMed ID: 30590102
[TBL] [Abstract][Full Text] [Related]
34. Potent anti-myeloma activity of the TOPK inhibitor OTS514 in pre-clinical models.
Stefka AT; Johnson D; Rosebeck S; Park JH; Nakamura Y; Jakubowiak AJ
Cancer Med; 2020 Jan; 9(1):324-334. PubMed ID: 31714026
[TBL] [Abstract][Full Text] [Related]
35. A mitotic kinase TOPK enhances Cdk1/cyclin B1-dependent phosphorylation of PRC1 and promotes cytokinesis.
Abe Y; Takeuchi T; Kagawa-Miki L; Ueda N; Shigemoto K; Yasukawa M; Kito K
J Mol Biol; 2007 Jul; 370(2):231-45. PubMed ID: 17512944
[TBL] [Abstract][Full Text] [Related]
36. PBK/TOPK in the differential diagnosis of cholangiocarcinoma from hepatocellular carcinoma and its involvement in prognosis of human cholangiocarcinoma.
He F; Yan Q; Fan L; Liu Y; Cui J; Wang J; Wang L; Wang Y; Wang Z; Guo Y; Huang G
Hum Pathol; 2010 Mar; 41(3):415-24. PubMed ID: 19954816
[TBL] [Abstract][Full Text] [Related]
37. Activation of TOPK by lipopolysaccharide promotes induction of inducible nitric oxide synthase through NF-κB activity in leukemia cells.
Park JH; Jeong YJ; Won HK; Choi SY; Park JH; Oh SM
Cell Signal; 2014 May; 26(5):849-56. PubMed ID: 24440499
[TBL] [Abstract][Full Text] [Related]
38. miR-216b promotes cell growth and enhances chemosensitivity of colorectal cancer by suppressing PDZ-binding kinase.
Zou J; Kuang W; Hu J; Rao H
Biochem Biophys Res Commun; 2017 Jun; 488(2):247-252. PubMed ID: 28373071
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-216b-3p inhibits lung adenocarcinoma cell growth via regulating PDZ binding kinase/T-LAK-cell-originated protein kinase.
Chai Y; Xue H; Wu Y; Du X; Zhang Z; Zhang Y; Zhang L; Zhang S; Zhang Z; Xue Z
Exp Ther Med; 2018 Jun; 15(6):4822-4828. PubMed ID: 29805502
[TBL] [Abstract][Full Text] [Related]
40. TOPK and PTEN participate in CHFR mediated mitotic checkpoint.
Shinde SR; Gangula NR; Kavela S; Pandey V; Maddika S
Cell Signal; 2013 Dec; 25(12):2511-7. PubMed ID: 24012691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
